More than 4.7 million new HIV treatments in 4 years
The World Health Organization (WHO) in 2018 recommended the use of a three-in-one combination of the antiretroviral drugs tenofovir, lamivudine, and dolutegravir (TLD) for the treatment of HIV. recommended In treatment guidelines in South Africa as first-line treatment for HIV, it was awarded a three-year tender. Since then, dolutegravir has largely replaced another antiretroviral called … Read more